ArticleScientific reports2025
Global, regional, and national burdens of alcohol-related cirrhosis among women from 1992 to 2021 and its predictions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Retrospective Analysis of Hepatic Disease Burden and Progression in a Hospital-Based Romanian Cohort Using Integrated Cross-Sectional and Longitudinal Data (2019-2023).Journal of clinical medicine · 2026Article
- Alcohol-related cirrhosis mortality, 1990-2021: temporal trends and development-level inequalities.Gastroenterology and hepatology from bed to bench · 2026Article
- Integrating Strategy of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Verification to Investigate the Potential Mechanism ofFoods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcohol-Related Cirrhosis (AC) has become a growing global health issue, particularly affecting women. This study provides a comprehensive analysis of the global, regional, and national burden of AC in women from 1992 to 2021, addressing a research gap by focusing on long-term trends specific to women. Using data from the Global Burden of Disease (GBD) 2021 database, we assessed trends in age-standardized incidence rates (ASIR), mortality rates (ASMR), and disability-adjusted life years (DALYs) for AC in women across 204 countries. Temporal trends were examined using the estimated annual percentage change (EAPC) method, and future projections to 2030 were generated using the Nordpred model. Between 1992 and 2021, the global ASIR of AC in women showed a slight decrease, from 3.10 to 2.42 per 100,000, with an EAPC of -1.02. A significant variation was observed across Socio-Demographic Index (SDI) regions, with the highest ASIR (3.77 per 100,000) reported in low-SDI regions in 2021. Mortality and DALYs also declined globally but remained disproportionately high in lower-SDI regions. The age distribution analysis revealed distinct gender-specific trends, with women experiencing a marked increase in AC burden in older age groups. Predictions indicate a further decline in AC burden by 2030, although the disease remains a significant public health concern. The findings highlight both global progress and persistent regional disparities in the burden of AC among women. Targeted public health interventions, particularly in lower-SDI regions, are essential to address the ongoing burden of this preventable disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.